Premier Biomedical Stock Today
| BIEI Stock | USD 0.0009 0.0001 10.00% |
Performance0 of 100
| Odds Of DistressOver 85
|
Premier Biomedical is trading at 9.0E-4 as of the 27th of November 2024. This is a 10 percent decrease since the beginning of the trading day. The stock's open price was 0.001. Premier Biomedical has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Premier Biomedical are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of October 2024 and ending today, the 27th of November 2024. Click here to learn more.
Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. Premier Biomedical, Inc. was founded in 2010 and is headquartered in Jackson Center, Pennsylvania. The company has 999.98 M outstanding shares. More on Premier Biomedical
Moving against Premier Pink Sheet
| 0.76 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.73 | CSCO | Cisco Systems Aggressive Push | PairCorr |
| 0.72 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.71 | HPQ | HP Inc | PairCorr |
| 0.63 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.61 | XOM | Exxon Mobil Corp Fiscal Year End 7th of February 2025 | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Premier Pink Sheet Highlights
| Business Concentration | Health Care, Biotechnology, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Premier Biomedical [BIEI] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.3 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Premier Biomedical's market, we take the total number of its shares issued and multiply it by Premier Biomedical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Premier Biomedical conducts business under Biotechnology sector and is part of Health Care industry. The entity has 999.98 M outstanding shares.
Premier Biomedical currently holds about 71.2 K in cash with (344.18 K) of positive cash flow from operations.
Check Premier Biomedical Probability Of Bankruptcy
Ownership AllocationPremier Biomedical owns a total of 999.98 Million outstanding shares. Roughly 97.64 pct. of Premier Biomedical outstanding shares are held by general public with 2.36 % owned by insiders and only 0.0 (%) by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Premier Ownership Details
Premier Biomedical Risk Profiles
| Mean Deviation | 7.11 | |||
| Standard Deviation | 10.84 | |||
| Variance | 117.48 | |||
| Risk Adjusted Performance | 0.0029 |
Premier Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Premier Biomedical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Rebalancing Now
Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets |
| All Next | Launch Module |
Other Information on Investing in Premier Pink Sheet
Premier Biomedical financial ratios help investors to determine whether Premier Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Premier with respect to the benefits of owning Premier Biomedical security.